Chih-Chi Andrew Hu, PhD

Projects

Projects per year 2021 2021 2028

• 1 Not started
• 4 Finished
• 5 Active

Projects per year

Search results

• Active

  Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer

  Hu, C. A.

  9/8/23 → 1/31/27

  Project: Federal Funding Agencies

• Mechanisms of STING in malignant progression and therapy of CLL.

  Hu, C. A.

  2/1/23 → 1/31/28

  Project: Federal Funding Agencies

• XBP1 Inhibition and STING activation for the treatment of cancer

  Hu, C. A.

  4/8/22 → 3/31/27

  Project: Federal Funding Agencies

• ER stress response and chronic lymphocytic leukemia

  Hu, C. A., Chaaya, G., Pingali, S. R. & Tang, C. A.

  9/3/21 → …

  Project: Clinical Trial

• Targeting ER stress response in B-cell chronic lymphocytic leukemia

  Hu, C. A., Pingali, S. R. & Tang, C. A.

  4/1/21 → 3/31/25

  Project: Federal Funding Agencies

• Not started

  Sample and Data Collection for Hematologic disorders section, Houston Methodist Cancer Center

  Pingali, S. R., Ganguly, S., Heyne, K., Hu, C. A., Jin, M. M., Rice, L., Shah, S., Yang, J., Yi, Q. & Zieske, A. W.

  Project: Clinical Trial

• Finished

  Targeting IRE-1a/XBP-1 Axis for Control of Chronic GVHD and Leukemia Relapse

  Hu, C. A.

  5/10/22 → 6/30/23

  Project: Federal Funding Agencies

• Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer

  Hu, C. A.

  8/1/21 → 1/31/23

  Project: Federal Funding Agencies

• African trypanosome parasites: a new tool to unveil potential immunological strategies totarget CLL

  Hu, C. A.

  5/3/21 → 4/30/24

  Project: Federal Funding Agencies

• Targeting IRE-1a/XBP-1 Axis for Control of Chronic GVHD and Leukemia Relapse

  Hu, C. A.

  4/1/21 → 1/12/22

  Project: Federal Funding Agencies